CN109400669A - 核桃仁皮的小分子蛋白质提取方法及应用 - Google Patents
核桃仁皮的小分子蛋白质提取方法及应用 Download PDFInfo
- Publication number
- CN109400669A CN109400669A CN201811486049.7A CN201811486049A CN109400669A CN 109400669 A CN109400669 A CN 109400669A CN 201811486049 A CN201811486049 A CN 201811486049A CN 109400669 A CN109400669 A CN 109400669A
- Authority
- CN
- China
- Prior art keywords
- walnut kernel
- kernel skin
- protein
- small molecular
- molecular protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 235000009496 Juglans regia Nutrition 0.000 title claims abstract description 90
- 235000020234 walnut Nutrition 0.000 title claims abstract description 90
- 102000004169 proteins and genes Human genes 0.000 title claims abstract description 78
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 78
- 238000000034 method Methods 0.000 title claims abstract description 24
- 240000007049 Juglans regia Species 0.000 title 1
- 241000758789 Juglans Species 0.000 claims abstract description 89
- 241000194032 Enterococcus faecalis Species 0.000 claims abstract description 14
- 241000589517 Pseudomonas aeruginosa Species 0.000 claims abstract description 13
- 229940032049 enterococcus faecalis Drugs 0.000 claims abstract description 13
- 230000000844 anti-bacterial effect Effects 0.000 claims abstract description 12
- 239000002246 antineoplastic agent Substances 0.000 claims abstract description 6
- 201000007270 liver cancer Diseases 0.000 claims abstract description 6
- 208000014018 liver neoplasm Diseases 0.000 claims abstract description 6
- 230000001093 anti-cancer Effects 0.000 claims abstract description 5
- 238000000926 separation method Methods 0.000 claims abstract description 4
- 229940079593 drug Drugs 0.000 claims description 9
- 239000003814 drug Substances 0.000 claims description 9
- 239000006228 supernatant Substances 0.000 claims description 9
- 238000002360 preparation method Methods 0.000 claims description 8
- 239000007788 liquid Substances 0.000 claims description 7
- 229920005654 Sephadex Polymers 0.000 claims description 5
- 238000010521 absorption reaction Methods 0.000 claims description 5
- 230000012010 growth Effects 0.000 claims description 5
- 150000003384 small molecules Chemical class 0.000 claims description 4
- 238000002835 absorbance Methods 0.000 claims description 3
- 239000000022 bacteriostatic agent Substances 0.000 claims description 3
- 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 claims description 3
- 238000001641 gel filtration chromatography Methods 0.000 claims description 3
- 239000000137 peptide hydrolase inhibitor Substances 0.000 claims description 3
- 239000002904 solvent Substances 0.000 claims description 3
- 239000012507 Sephadex™ Substances 0.000 claims description 2
- 238000005119 centrifugation Methods 0.000 claims description 2
- 210000002784 stomach Anatomy 0.000 claims description 2
- 230000001225 therapeutic effect Effects 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 11
- 230000002401 inhibitory effect Effects 0.000 abstract description 9
- 230000004083 survival effect Effects 0.000 abstract description 9
- 238000012360 testing method Methods 0.000 abstract description 8
- 101000600434 Homo sapiens Putative uncharacterized protein encoded by MIR7-3HG Proteins 0.000 abstract description 7
- 102100037401 Putative uncharacterized protein encoded by MIR7-3HG Human genes 0.000 abstract description 7
- 230000003385 bacteriostatic effect Effects 0.000 abstract description 4
- 230000004663 cell proliferation Effects 0.000 abstract description 4
- 201000006585 gastric adenocarcinoma Diseases 0.000 abstract description 4
- 238000011160 research Methods 0.000 abstract description 3
- 238000010266 Sephadex chromatography Methods 0.000 abstract description 2
- 235000018102 proteins Nutrition 0.000 abstract 6
- 229940088710 antibiotic agent Drugs 0.000 abstract 1
- 229940041181 antineoplastic drug Drugs 0.000 abstract 1
- 235000004252 protein component Nutrition 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 55
- 210000004027 cell Anatomy 0.000 description 19
- 239000000243 solution Substances 0.000 description 16
- 241000894006 Bacteria Species 0.000 description 8
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 8
- 238000002474 experimental method Methods 0.000 description 7
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 5
- 210000002540 macrophage Anatomy 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 238000001514 detection method Methods 0.000 description 4
- 230000005764 inhibitory process Effects 0.000 description 4
- 244000005700 microbiome Species 0.000 description 4
- 241000588724 Escherichia coli Species 0.000 description 3
- 238000005227 gel permeation chromatography Methods 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 210000003292 kidney cell Anatomy 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical compound N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- AZKSAVLVSZKNRD-UHFFFAOYSA-M 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide Chemical compound [Br-].S1C(C)=C(C)N=C1[N+]1=NC(C=2C=CC=CC=2)=NN1C1=CC=CC=C1 AZKSAVLVSZKNRD-UHFFFAOYSA-M 0.000 description 2
- 241000588626 Acinetobacter baumannii Species 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 241000222122 Candida albicans Species 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- 241000588747 Klebsiella pneumoniae Species 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 2
- 241000191984 Staphylococcus haemolyticus Species 0.000 description 2
- 241000192097 Staphylococcus sciuri Species 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 229940095731 candida albicans Drugs 0.000 description 2
- 230000010261 cell growth Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 238000000502 dialysis Methods 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 230000001408 fungistatic effect Effects 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 229940045505 klebsiella pneumoniae Drugs 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000012460 protein solution Substances 0.000 description 2
- 239000011435 rock Substances 0.000 description 2
- 230000009758 senescence Effects 0.000 description 2
- 229910000162 sodium phosphate Inorganic materials 0.000 description 2
- 210000004988 splenocyte Anatomy 0.000 description 2
- 229940037649 staphylococcus haemolyticus Drugs 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 238000002604 ultrasonography Methods 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 241001478240 Coccus Species 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- 206010014476 Elevated cholesterol Diseases 0.000 description 1
- 241000848296 Endopleura Species 0.000 description 1
- 241000194033 Enterococcus Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 208000035150 Hypercholesterolemia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 239000005864 Sulphur Substances 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 238000011319 anticancer therapy Methods 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000009702 cancer cell proliferation Effects 0.000 description 1
- 230000005907 cancer growth Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000007073 chemical hydrolysis Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229940000425 combination drug Drugs 0.000 description 1
- 230000001143 conditioned effect Effects 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 230000009701 normal cell proliferation Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 210000004989 spleen cell Anatomy 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- -1 sulphur Amine Chemical class 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 238000002525 ultrasonication Methods 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/145—Extraction; Separation; Purification by extraction or solubilisation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Analytical Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811486049.7A CN109400669B (zh) | 2018-12-06 | 2018-12-06 | 核桃仁皮的小分子蛋白质提取方法及应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811486049.7A CN109400669B (zh) | 2018-12-06 | 2018-12-06 | 核桃仁皮的小分子蛋白质提取方法及应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN109400669A true CN109400669A (zh) | 2019-03-01 |
CN109400669B CN109400669B (zh) | 2021-08-20 |
Family
ID=65457523
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811486049.7A Active CN109400669B (zh) | 2018-12-06 | 2018-12-06 | 核桃仁皮的小分子蛋白质提取方法及应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109400669B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114752585A (zh) * | 2022-05-20 | 2022-07-15 | 山西大学 | 一种核桃青皮抗肿瘤活性蛋白及其制备方法和应用 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101185671A (zh) * | 2007-12-07 | 2008-05-28 | 贵州大学 | 从核桃树皮中提取的抗肿瘤药物及其制备方法 |
WO2013191565A1 (en) * | 2012-06-18 | 2013-12-27 | Waikatolink Limited | Antimicrobial composition and its method of use |
CN104152520A (zh) * | 2014-07-30 | 2014-11-19 | 华南理工大学 | 一种具有抗肿瘤活性的核桃多肽-锌螯合物的制备方法 |
CN105061382A (zh) * | 2015-08-11 | 2015-11-18 | 张初署 | 一种黑花生衣原花色素和富硒蛋白同步提取方法 |
-
2018
- 2018-12-06 CN CN201811486049.7A patent/CN109400669B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101185671A (zh) * | 2007-12-07 | 2008-05-28 | 贵州大学 | 从核桃树皮中提取的抗肿瘤药物及其制备方法 |
WO2013191565A1 (en) * | 2012-06-18 | 2013-12-27 | Waikatolink Limited | Antimicrobial composition and its method of use |
CN104152520A (zh) * | 2014-07-30 | 2014-11-19 | 华南理工大学 | 一种具有抗肿瘤活性的核桃多肽-锌螯合物的制备方法 |
CN105061382A (zh) * | 2015-08-11 | 2015-11-18 | 张初署 | 一种黑花生衣原花色素和富硒蛋白同步提取方法 |
Non-Patent Citations (5)
Title |
---|
RAHELEH JAHANBANI等: "Antioxidant and Anticancer Activities of Walnut (Juglans regia L.) Protein Hydrolysates Using Different Proteases", 《PLANT FOODS HUM NUT》 * |
TIAN-PENG YIN等: "Tannins and Antioxidant Activities of the Walnut (Juglans regia) Pellicle", 《NATURAL PRODUCT COMMUNICATIONS》 * |
余永婷等: "超声波-微波协同辅助法提取核桃蛋白工艺优化及特性研究", 《食品研究与开发》 * |
翟梦新等: "核桃蛋白生物活性的研究进展", 《中国食物与营养》 * |
荣瑞芬等: "核桃内种皮营养与功能成分初步分析研究", 《食品科学》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114752585A (zh) * | 2022-05-20 | 2022-07-15 | 山西大学 | 一种核桃青皮抗肿瘤活性蛋白及其制备方法和应用 |
CN114752585B (zh) * | 2022-05-20 | 2023-07-18 | 山西大学 | 一种核桃青皮抗肿瘤活性蛋白及其制备方法和应用 |
Also Published As
Publication number | Publication date |
---|---|
CN109400669B (zh) | 2021-08-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102210717B (zh) | 含有与丹宁组合的植物乳杆菌菌株的组合物和新植物乳杆菌菌株 | |
JP6626902B2 (ja) | 抗菌漢方薬組成物、その製造方法および使用方法 | |
CN105801690B (zh) | 一种胰蛋白酶抑制剂及其制备方法和应用 | |
CN112451488A (zh) | 一种植物来源类外泌体制品的制备方法和应用 | |
CN107751697A (zh) | 小球藻精藻蓝蛋白功能饮品制备方法 | |
CN115772550A (zh) | 一种具有抗氧化活性和保肝功效的草菇多肽的制备方法 | |
Hamed et al. | Antimicrobial activities of lectins extracted from some cultivars of Phaseolus vulgaris seeds | |
CN104367987B (zh) | 兽用黄芪制剂及其制备方法 | |
CN114306511B (zh) | 一种复方组合物及其在制备用于防治马拉色菌属病菌引起的皮肤疾病的药物中的应用 | |
CN107708445A (zh) | 竹发酵提取物的制造方法及免疫赋活剂 | |
Parnomo | Effect of arabica coffee bean extract (Coffea arabica) as a growth inhibitor of Enterococcus faecalis ATCC 29212 | |
JP3471789B2 (ja) | アレルギー疾患治療剤およびその製造方法 | |
CN109400669A (zh) | 核桃仁皮的小分子蛋白质提取方法及应用 | |
KR102099788B1 (ko) | 왜주름불가사리 추출물을 유효성분으로 함유하는 항산화 및 항염증용 조성물 및 그 제조 방법 | |
CN106434477A (zh) | 一种葛仙米异形胞嵌悬育种方法 | |
CN105294872A (zh) | 一种羧甲基化梭柄松苞菇多糖的制备方法 | |
CN109674051A (zh) | 一种乳酸菌发酵富集元麦多酚及制备抗氧化剂的方法 | |
CN106434787B (zh) | 一种玉米种皮多糖复合物及制备方法和医疗用途 | |
CN104450541B (zh) | 一株藏红花内生真菌及其粗多糖和制备方法与用途 | |
KR100517354B1 (ko) | 해조류 유래 올리고당, 상기 올리고당의 제조방법 및사용방법 | |
CN105085647A (zh) | 天然抗感染抗氧化双功能肽Pb-CATH2及其基因与应用 | |
Niekraszewicz et al. | Biopolymer compositions for ecological protection and growth stimulation of plants | |
CN109771452A (zh) | 虎奶菇提取物在制备治疗肿瘤药物中的应用 | |
JP2002272267A (ja) | 冬虫夏草の人工培養方法並びにハナサナギタケの抽出組成物及びそれを用いた機能性食品 | |
CN109652479A (zh) | 一种提高石斛多糖抗氧化能力的方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
OL01 | Intention to license declared | ||
OL01 | Intention to license declared | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20190301 Assignee: Yunnan Linkang Biotechnology Co.,Ltd. Assignor: SOUTHWEST FORESTRY University Contract record no.: X2024980006840 Denomination of invention: Extraction Method and Application of Small Molecule Proteins from Walnut Peel Granted publication date: 20210820 License type: Open License Record date: 20240607 |
|
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20190301 Assignee: Kunming Zhuote Biotechnology Co.,Ltd. Assignor: SOUTHWEST FORESTRY University Contract record no.: X2024980007439 Denomination of invention: Extraction Method and Application of Small Molecule Proteins from Walnut Peel Granted publication date: 20210820 License type: Open License Record date: 20240624 |
|
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20190301 Assignee: Kunming Xinfan Biotechnology Co.,Ltd. Assignor: SOUTHWEST FORESTRY University Contract record no.: X2024980007426 Denomination of invention: Extraction Method and Application of Small Molecule Proteins from Walnut Peel Granted publication date: 20210820 License type: Open License Record date: 20240624 |